Literature DB >> 21748932

Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.

Yao-Hua Li1, Nan Gao, Yi-Wen Ye, Xin Li, Shun Yu, Hui Yang, Kenji Uéda, Piu Chan.   

Abstract

Previous studies have shown that over-expression of alpha-Synuclein (alpha-Syn), a protein whose abnormality is implicated in the pathogenesis of Parkinson's disease (PD), reduces tyrosine hydroxylase (TH) expression and dopamine synthesis. To explore the possible mechanism for the regulation of TH expression by alpha-Syn, luciferase reporter gene carrying a -493/+27bp fragment of human TH gene (pGL3-TH520) and pcDNA carrying halpha-Syn gene (pcDNA-halpha-Syn) were co-transfected into T293 cells. The results showed that alpha-Syn was only detected in pcDNA-halpha-Syn-transfected cells but not in pcDNA vector control cells. In alpha-Syn-transfected cells, the luciferase activity was dramatically reduced compared with the vector control cells. These results suggest that alpha-Syn may function as a negative regulator for TH expression by affecting the activity of TH promoter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748932

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  10 in total

Review 1.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

2.  Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.

Authors:  Xiu-Qi Bao; Liang-Yu Wu; Xiao-Liang Wang; Hua Sun; Dan Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-13       Impact factor: 3.000

3.  iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.

Authors:  A H Laperle; S Sances; N Yucer; V J Dardov; V J Garcia; R Ho; A N Fulton; M R Jones; K M Roxas; P Avalos; D West; M G Banuelos; Z Shu; R Murali; N T Maidment; J E Van Eyk; M Tagliati; C N Svendsen
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

Review 4.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

5.  Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.

Authors:  Jenny-Ann Phan; Kathrine Stokholm; Justyna Zareba-Paslawska; Steen Jakobsen; Kim Vang; Albert Gjedde; Anne M Landau; Marina Romero-Ramos
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

6.  Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity.

Authors:  Matthew J Benskey; Rhyomi C Sellnow; Ivette M Sandoval; Caryl E Sortwell; Jack W Lipton; Fredric P Manfredsson
Journal:  Front Mol Neurosci       Date:  2018-02-13       Impact factor: 5.639

Review 7.  Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson's disease.

Authors:  Aishwarya S Kulkarni; Matthew R Burns; Patrik Brundin; Daniel W Wesson
Journal:  Brain Commun       Date:  2022-06-22

Review 8.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 9.  The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.

Authors:  Christine Kaindlstorfer; Kurt A Jellinger; Sabine Eschlböck; Nadia Stefanova; Günter Weiss; Gregor K Wenning
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Neurons and Glia Interplay in α-Synucleinopathies.

Authors:  Panagiota Mavroeidi; Maria Xilouri
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.